Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Allan Musinguzi

6PUBLICATIONS

21CO-AUTHORS

Behavioural epidemiologyEpidemiological methodsRehabilitation engineeringPreventative health care

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Mar 31, 2025

Predicted choice and acceptability of regimens for tuberculosis preventive treatment among people living with HIV in Uganda - a discrete choice experiment.

Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota

|Nov 25, 2024

Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda.

Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann

|Oct 24, 2024

Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.

Allan Musinguzi, Joan R Kasidi, Jillian L Kadota

|Sep 24, 2024

Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.

Allan Musinguzi, Joan R Kasidi, Jillian L Kadota

|Aug 16, 2024

Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda.

Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann

|Feb 20, 2024

Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.

Fred C Semitala, Jillian L Kadota, Allan Musinguzi

Pageof 1

Frequent Collaborators

6 joint publications

Jillian L Kadota

5 joint publications

Patrick Pj Phillips

5 joint publications

Adithya Cattamanchi

4 joint publications

Fred C Semitala

4 joint publications

Hélène E Aschmann

4 joint publications

Noah Kiwanuka

3 joint publications

Joan Ritar Kasidi

3 joint publications

Devika Patel

3 joint publications

Moses R Kamya

3 joint publications

Anne R Katahoire

Frequent Collaborators

6 joint publications

Jillian L Kadota

5 joint publications

Patrick Pj Phillips

5 joint publications

Adithya Cattamanchi

4 joint publications

Fred C Semitala

Top Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on : Mar 30, 2014

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on : Apr 09, 2014

See more related videos

Top Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on : Mar 30, 2014

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on : Apr 09, 2014

See more related videos